PRKAA2 and colorectal cancer: While there is limited evidence demonstrating a direct link, several studies were able to show a correlation between AMPK activation by numerous agents and COX-2 inhibition in colorectal cancer cell lines and xenografts [75, 76], as well as, leukemic [77] and melanoma cell lines [11].